Ovarian cancer is the eighth most common cancer among women and has a 5-year survival of only 30-50%. The survival is close to 90% for patients in stage I but only 20% for patients in stage IV. The presently available biomarkers have insufficient sensitivity and specificity for early detection and there is an urgent need to identify novel biomarkers...Read more
May 30, 2022 - May 31, 2022
Cecilia Lindskog will present "The Human Protein Atlas - spatial proteomics for single cell analysis"Jochen Schwenk will talk on the subject "Precision phenotyping with the circulating proteome"
September 11, 2022 - September 16, 2022
FEBS Practical and Lecture Course - A summer school aimed at graduate students, post-docs, and young independent investigators who want to learn about new techniques to explore the proteins encoded by the human genome.News article